Ryszard Bugno

608 total citations
36 papers, 429 citations indexed

About

Ryszard Bugno is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Ryszard Bugno has authored 36 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 17 papers in Organic Chemistry. Recurrent topics in Ryszard Bugno's work include Receptor Mechanisms and Signaling (15 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). Ryszard Bugno is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). Ryszard Bugno collaborates with scholars based in Poland, Italy and France. Ryszard Bugno's co-authors include Andrzej J. Bojarski, Beata Duszyńska, Maria H. Paluchowska, Adam S. Hogendorf, E Chojnacka-Wójcik, E Tatarczyńska, Jakub Staroń, Tomasz Lenda, Agnieszka Nikiforuk and Grzegorz Satała and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Ryszard Bugno

36 papers receiving 425 citations

Peers

Ryszard Bugno

CMN

PHARM

CTM

Adam S. Hogendorf Poland

Michelle Vanase‐Frawley United States

Vittorio Canale Poland

Anikó Gere Hungary

Gabriela Starowicz Poland

Małgorzata Wolak Poland

Carl Haslam United Kingdom

Jason D. Speake United States

Christoph van Amsterdam Germany

Lee-Yuh Pai United States

Adam S. Hogendorf Poland

Ryszard Bugno

113 ×0.5

114 ×0.7

64 ×0.4

CMN

40 ×0.8

PHARM

39 ×0.8

CTM

Citations per year, relative to Ryszard Bugno Ryszard Bugno (= 1×) peers Adam S. Hogendorf

Countries citing papers authored by Ryszard Bugno

Since Specialization

Citations

This map shows the geographic impact of Ryszard Bugno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryszard Bugno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryszard Bugno more than expected).

Fields of papers citing papers by Ryszard Bugno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryszard Bugno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryszard Bugno. The network helps show where Ryszard Bugno may publish in the future.

Co-authorship network of co-authors of Ryszard Bugno

This figure shows the co-authorship network connecting the top 25 collaborators of Ryszard Bugno. A scholar is included among the top collaborators of Ryszard Bugno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryszard Bugno. Ryszard Bugno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kolasa, Magdalena, Agnieszka Nikiforuk, Agnieszka Potasiewicz, et al.. (2024). Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression. Psychopharmacology. 242(7). 1607–1625. 7 indexed citations

Wątor, Katarzyna, et al.. (2024). Assessing health risks in bottled water: chemical compounds and their impact on human health. Environmental Geochemistry and Health. 46(6). 178–178. 5 indexed citations

Stankiewicz, Anna, Ryszard Bugno, Maria H. Paluchowska, et al.. (2023). Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties. International Journal of Molecular Sciences. 24(3). 1981–1981. 8 indexed citations

Popik, Piotr, Adam S. Hogendorf, Ryszard Bugno, et al.. (2022). Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats. Psychopharmacology. 239(6). 1689–1703. 18 indexed citations

Rafało-Ulińska, Anna, Bartłomiej Pochwat, Paulina Misztak, et al.. (2022). Zinc Deficiency Blunts the Effectiveness of Antidepressants in the Olfactory Bulbectomy Model of Depression in Rats. Nutrients. 14(13). 2746–2746. 5 indexed citations

Stankiewicz, Anna, Ryszard Bugno, Maria H. Paluchowska, et al.. (2021). New 1,2,4-oxadiazole derivatives with positive mGlu ₄ receptor modulation activity and antipsychotic-like properties. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 211–225. 4 indexed citations

Kmiecik, Ewa, et al.. (2021). Pharmaceuticals and personal care products in the urban groundwater – preliminary monitoring (case study: Kraków, Southern Poland). Urban Water Journal. 18(5). 364–374. 22 indexed citations

Bugno, Ryszard, et al.. (2021). Comparison of an Addictive Potential of μ-Opioid Receptor Agonists with G Protein Bias: Behavioral and Molecular Modeling Studies. Pharmaceutics. 14(1). 55–55. 5 indexed citations

Staroń, Jakub, Ryszard Bugno, Rafał Kurczab, et al.. (2021). Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands – Fluoxetine and fluvoxamine. European Journal of Medicinal Chemistry. 220. 113533–113533. 20 indexed citations

10.

Podlewska, Sabina, Ryszard Bugno, Enza Lacivita, et al.. (2021). Low Basicity as a Characteristic for Atypical Ligands of Serotonin Receptor 5-HT2. International Journal of Molecular Sciences. 22(3). 1035–1035. 3 indexed citations

11.

Hogendorf, Adam S., Rafał Kurczab, Grzegorz Satała, et al.. (2021). N-Skatyltryptamines—Dual 5-HT6R/D2R Ligands with Antipsychotic and Procognitive Potential. Molecules. 26(15). 4605–4605. 4 indexed citations

12.

Zajdel, Paweł, Katarzyna Grychowska, Szczepan Mogilski, et al.. (2021). Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT₃ and 5-HT₆ Receptor Antagonist with Antipsychotic and Procognitive Properties. Journal of Medicinal Chemistry. 64(18). 13279–13298. 11 indexed citations

13.

Staroń, Jakub, Ryszard Bugno, Grzegorz Satała, et al.. (2020). Rationally designed N-phenylsulfonylindoles as a tool for the analysis of the non-basic 5-HT6R ligands binding mode. European Journal of Medicinal Chemistry. 209. 112916–112916. 3 indexed citations

14.

Podlewska, Sabina, et al.. (2020). Molecular Modeling of µ Opioid Receptor Ligands with Various Functional Properties: PZM21, SR-17018, Morphine, and Fentanyl—Simulated Interaction Patterns Confronted with Experimental Data. Molecules. 25(20). 4636–4636. 23 indexed citations

15.

Staroń, Jakub, Rafał Kurczab, Dawid Warszycki, et al.. (2019). Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties. European Journal of Medicinal Chemistry. 185. 111857–111857. 31 indexed citations

16.

Jarończyk, Małgorzata, Mirosława Koronkiewicz, Jerzy Kossakowski, et al.. (2018). Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT1A Receptor Ligands. International Journal of Molecular Sciences. 19(10). 3260–3260. 5 indexed citations

17.

Bugno, Ryszard, et al.. (2010). SAR studies on new bis-aryls 5-HT7 ligands: Synthesis and molecular modeling. Bioorganic & Medicinal Chemistry. 18(5). 1958–1967. 12 indexed citations

18.

Paluchowska, Maria H., Ryszard Bugno, Sijka Charakchieva‐Minol, et al.. (2006). Conformational Restriction in Novel NAN‐190 and MP3022 Analogs and Their 5‐HT_1A Receptor Activity. Archiv der Pharmazie. 339(9). 498–506. 15 indexed citations

19.

Bojarski, Andrzej J., Maria H. Paluchowska, Beata Duszyńska, et al.. (2005). Structure–intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic- like activity. Bioorganic & Medicinal Chemistry. 14(5). 1391–1402. 19 indexed citations

20.

Zajdel, Paweł, Andrzej J. Bojarski, Ryszard Bugno, et al.. (2004). A study on application of impregnated synthetic peptide TLC stationary phases for the screening of 5‐HT_1A ligands. Part 2. Biomedical Chromatography. 18(8). 542–549. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact